Severity, reduction or cessation in nausea/vomiting 2. Quality of life outcomes 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity, reduction or cessation in nausea/vomiting 2.Days of hospital admission 3. Pregnancy complications 4. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Preterm birth · Pregnant women with hyperemesis gravidarum
Acupuncture showed no clear difference in preterm birth less than 37 weeks compared with placebo (low certainty).
1 finding from 1 review
Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Days of hospital admission 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity, reduction or cessation in nausea/vomiting 2. Number of episodes of emesis 3. Quality of life outcomes 4. Pregnancy complications 5. Adverse fetal/neonatal outcomes · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Preterm birth · Pregnant women with hyperemesis gravidarum
Corticosteroids showed no clear difference in preterm birth compared with promethazine (low certainty).
1 finding from 1 review
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy complications · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes pregnancy complications compared with placebo (very low certainty).
1 finding from 1 review
Preterm birth · Pregnant women with hyperemesis gravidarum
It is very uncertain whether corticosteroids changes preterm birth compared with placebo (very low certainty).
1 finding from 1 review
Duration of hospital admission (days) · Pregnant women with hyperemesis gravidarum
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Preterm birth · pregnant women
Balanced protein and energy supplementation showed no clear difference in preterm birth compared with control or no intervention (moderate certainty).
1 finding from 1 review
Intervention not reported
Preterm birth · pregnant women
The intervention showed no clear difference in preterm birth (low certainty).
1 finding from 1 review
Intervention not reported
Preterm birth · pregnant women
1 finding from 1 review
Gestational age (preterm birth < 37 weeks) · pregnant women accessing prenatal care
Group antenatal care showed no clear difference in preterm birth (gestational age at time of birth less than 37 weeks'… compared with individual antenatal care (adjusted data) (moderate certainty).
1 finding from 1 review
Pregnancy‐related deaths · pregnant women
One intervention showed no clear difference in pregnancy‐related deaths compared with no intervention (low certainty).
1 finding from 1 review
Pregnancy‐related deaths · pregnant women
Combination of interventions showed no clear difference in pregnancy‐related deaths compared with no intervention (moderate certainty).
1 finding from 1 review
Incidence of Rhesus D alloimmunisation postpartum (at birth of Rh‐positive infant and at · Rh‐negative women without anti‐D antibodies
Anti‐D administration in pregnancy showed no clear difference in incidence of Rhesus D alloimmunisation postpartum (at birth of… compared with no treatment (low certainty).
1 finding from 1 review
Incidence of positive Kleihauer test (at 32 to 35 weeks' gestation) · Rh‐negative women without anti‐D antibodies
Anti‐D administration in pregnancy may leads to lower incidence of positive Kleihauer test (at 32 to 35 weeks' gestation) compared with no treatment (low certainty).
1 finding from 1 review
Incidence of positive Kleihauer test (at birth of a Rh‐positive infant) · Rh‐negative women without anti‐D antibodies
Anti‐D administration in pregnancy may leads to lower incidence of positive Kleihauer test (at birth of a Rh‐positive… compared with no treatment (low certainty).
1 finding from 1 review
Neonatal jaundice · Rh‐negative women without anti‐D antibodies
It is very uncertain whether anti‐D administration in pregnancy changes neonatal jaundice compared with no treatment (very low certainty).
1 finding from 1 review